12/19/2017 – Update for the Registration of Independent Testing Laboratories
On December 19, 2017, the Department issued the Policy on Laboratory Registration, which provides guidance regarding the timeline for laboratories to apply for a Certificate of Registration to operate as an Independent Testing Laboratory (ITL) with the Medical Use of Marijuana Program.
For more information about Independent Testing Laboratory Registration with the Medical Use of Marijuana Program, please visit the Apply for an Independent Testing Laboratory Certificate of Registration page.
12/01/2017 – New Guidance for RMDs and Testing Laboratories
On December 1, 2017, the Department issued the Policy on Contamination Notification Requirement for Independent Testing Laboratories and Registered Marijuana Dispensaries (RMD) and the Policy on Acquisition of Cuttings or Genetic Plant Material for RMDs.
The Policy on Contamination Notification Requirement (PDF) | (DOCX) outlines the requirements for both testing laboratories and Registered Marijuana Dispensaries to notify the Department of laboratory results indicating the contaminant levels in a tested product exceed the acceptable limits outlined in the Protocol for Sampling and Analysis of Finished Medical Marijuana Products and Marijuana-Infused Products and cannot be remediated.
The Policy on Acquisition of Cuttings or Genetic Plant Material (PDF) | (DOCX) outlines the guidelines for organizations that have received at least a Provisional Certificate of Registration (PCR) to obtain cuttings or genetic plant materials.
12/01/2017 – Revised Medical Use of Marijuana Regulations
The revised Medical Use of Marijuana regulations, Implementation of an Act for the Humanitarian Medical Use of Marijuana, were approved by the Public Health Council on Wednesday, November 8, 2017. The regulations went in to effect on Friday, December 1, 2017.
To access the revised regulations, please visit the Medical Use of Marijuana laws, regulations, and reports page.